TAVR use is growing in patients with less than high surgical risk. Several registries, including this one, show excellent safety with TAVR in intermediate-risk patients compared with similar patients undergoing SAVR. Long-term data from ongoing randomized trials will answer definitively if we should routinely perform TAVR in intermediate-risk patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ccd.26228 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!